Live feed08:00:00·44mPRReleasevia QuantisnowLantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s DiseaseByQuantisnow·Wall Street's wire, on your screen.LNTH· Lantheus Holdings Inc.Health Care
